Cargando…
Androgen receptor axis-targeted agents are not superior to conventional hormonal therapy for treatment of metastatic prostate cancer
The present study aimed to use real-world Japanese data to compare the treatment outcome of conventional hormonal therapy to that of using androgen receptor axis-targeted (ARAT) agents for patients with metastatic castration-resistant prostate cancer. The overall survival between the conventional ho...
Autores principales: | Wada, Akinori, Narita, Mitsuhiro, Nagasawa, Masayuki, Kusaba, Takuto, Kubota, Shigehisa, Yoshida, Tetsuya, Johnin, Kazuyoshi, Kawauchi, Akihiro, Kageyama, Susumu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404690/ https://www.ncbi.nlm.nih.gov/pubmed/36039059 http://dx.doi.org/10.3892/ol.2022.13453 |
Ejemplares similares
-
Prognostic nutritional index of early post-pembrolizumab therapy predicts long-term survival in patients with advanced urothelial carcinoma
por: Kageyama, Susumu, et al.
Publicado: (2022) -
The location of the bladder neck in postoperative cystography predicts continence convalescence after radical prostatectomy
por: Kageyama, Susumu, et al.
Publicado: (2018) -
Long-Term Prostate-Specific Antigen Response on a Low-Dose Cabazitaxel Regimen for Metastatic Castration-Resistant Prostate Cancer: A Case Report
por: Kubota, Shigehisa, et al.
Publicado: (2021) -
Prediction of intravesical recurrence of non-muscle-invasive bladder cancer by evaluation of intratumoral Foxp3(+) T cells in the primary transurethral resection of bladder tumor specimens
por: Murai, Ryosuke, et al.
Publicado: (2018) -
Efficient Prostate Cancer Therapy with Tissue-Specific Homing Peptides Identified by Advanced Phage Display Technology
por: Wada, Akinori, et al.
Publicado: (2019)